Imbricatolic acid

Imbricatolic acid
Product Name Imbricatolic acid
CAS No.: 6832-60-6
Catalog No.: CFN97164
Molecular Formula: C20H34O3
Molecular Weight: 322.5 g/mol
Purity: >=98%
Type of Compound: Diterpenoids
Physical Desc.: Powder
Targets: p53
Source: The barks of Pinus massoniana Lamb.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
Imbricatolic acid can prevent cell cycle progression in p53-null CaLu-6 cells.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Am J Chin Med.2016, 44(6):1255-1271
  • Appl. Sci. 2021, 11(10),4666.
  • Front Pharmacol.2021, 12:744624.
  • Evid Based Complement Alternat Med.2021, 8707280.
  • J Med Chem.2023, 66(6):4106-4130.
  • Biol Pharm Bull.2018, 41(1):65-72
  • Semyung University2017, 149407
  • Cell Rep.2020, 32(11):108158.
  • ACS Nano.2023, 17(11):9972-9986.
  • The Malaysian journal of pathology2019, 41(3):243-251
  • ent-Labda-8(17),13Z-diene-15,16,19-triol 19-O-glucoside

    Catalog No: CFN96078
    CAS No: 1245636-01-4
    Price: Inquiry(manager@chemfaces.com)
    Goshonoside F1

    Catalog No: CFN89220
    CAS No: 90851-24-4
    Price: Inquiry(manager@chemfaces.com)
    Goshonoside F5

    Catalog No: CFN89238
    CAS No: 90851-28-8
    Price: Inquiry(manager@chemfaces.com)
    Agatholal

    Catalog No: CFN98497
    CAS No: 3650-31-5
    Price: Inquiry(manager@chemfaces.com)
    Imbricatolic acid

    Catalog No: CFN97164
    CAS No: 6832-60-6
    Price: Inquiry(manager@chemfaces.com)
    Isocupressic acid

    Catalog No: CFN99882
    CAS No: 1909-91-7
    Price: Inquiry(manager@chemfaces.com)
    Acetylisocupressic acid

    Catalog No: CFN98880
    CAS No: 52992-82-2
    Price: Inquiry(manager@chemfaces.com)
    Scoparinol

    Catalog No: CFN99397
    CAS No: 130838-00-5
    Price: Inquiry(manager@chemfaces.com)
    Agathadiol diacetate

    Catalog No: CFN98250
    CAS No: 24022-13-7
    Price: Inquiry(manager@chemfaces.com)
    ent-Labda-8(17),13E-diene-3beta,15,18-triol

    Catalog No: CFN89384
    CAS No: 90851-50-6
    Price: Inquiry(manager@chemfaces.com)
    Planta Med. 2011 Nov;77(16):1822-8.
    Imbricatolic acid from Juniperus communis L. prevents cell cycle progression in CaLu-6 cells.[Pubmed: 21567359]

    METHODS AND RESULTS:
    Imbricatolic acid was isolated from the methanolic extract of the fresh ripe berries of Juniperus communis (Cupressaceae) together with sixteen known compounds and a new dihydrobenzofuran lignan glycoside named juniperoside A. Their structures were determined by spectroscopic methods and by comparison with the spectral data reported in literature. Imbricatolic acid was evaluated for its ability to prevent cell cycle progression in p53-null CaLu-6 cells. This compound induces the upregulation of cyclin-dependent kinase inhibitors and their accumulation in the G1 phase of the cell cycle, as well as the degradation of cyclins A, D1, and E1. Furthermore, no significant Imbricatolic acid-induced apoptosis was observed.
    CONCLUSIONS:
    Therefore, this plant-derived compound may play a role in the control of cell cycle.
    Molecules. 2007 May 21;12(5):1092-100.
    Biotransformations of imbricatolic acid by Aspergillus niger and Rhizopus nigricans cultures.[Pubmed: 17873843]

    METHODS AND RESULTS:
    Microbial transformation of Imbricatolic acid (1) by Aspergillus niger afforded 1alpha-hydroxyImbricatolic acid (2), while transformation with Rhizopus nigricans yielded 15-hydroxy-8,17-epoxylabdan-19-oic acid (3). When the diterpene 1 was added to a Cunninghamella echinulata culture, the main products were the microbial metabolites mycophenolic acid (4) and its 3-hydroxy derivative 5. All the structures were elucidated by spectroscopic methods. The cytotoxicity of these compounds towards human lung fibroblasts and AGS cells was assessed.
    CONCLUSIONS:
    While 4 and 5 showed low cytotoxicity, with IC50 values > 1000 microM against AGS cells and fibroblasts, 1alpha-hydroxyImbricatolic acid (2) presented moderate toxicity towards these targets, with IC50 values of 307 and 631 microM, respectively. The structure of 2 is presented for the first time.
    Bioorg Med Chem Lett. 2012 Jul 15;22(14):4636-9.
    Synthesis of novel imbricatolic acid analogues via insertion of N-substituted piperazine at C-15/C-19 positions, displaying glucose uptake stimulation in L6 skeletal muscle cells.[Pubmed: 22726926 ]

    METHODS AND RESULTS:
    A new class of N-substituted piperazine analogues of Imbricatolic acid have been designed and synthesized by using the appropriate synthetic routes in excellent yield. All synthesised compounds were screened for their in vitro glucose uptake stimulatory activity. Among them compounds 4b, 4e, 8b, and 8e triggered L6 skeletal muscle cells for glucose uptake at 54.73%, 40.79%, 40.90%, and 39.55% stimulation, respectively. Compound 4b has emerged as important lead compound showing potential antidiabetic activity.
    CONCLUSIONS:
    Illustration about their synthesis and in vitro glucose uptake activity is described.
    24-Hydroxymomordicine III

    Catalog No: CFN95169
    CAS No: N/A
    Price: $318/5mg
    Astin C

    Catalog No: CFN95189
    CAS No: 148057-23-2
    Price: $318/10mg
    Arisanschinin E

    Catalog No: CFN95221
    CAS No: 1333378-33-8
    Price: Inquiry(manager@chemfaces.com)
    Bidenoside C

    Catalog No: CFN95266
    CAS No: 700877-55-0
    Price: $318/5mg
    Somnifericin

    Catalog No: CFN95280
    CAS No: 173693-57-7
    Price: $318/5mg
    (3beta,22alpha)-26-(beta-glucopyranosyloxy)-22-methoxyfurost-5-en-3-yl 2-O-(6-deoxy-alpha-mannopyranosyl)-beta-glucopyranosiduronic acid

    Catalog No: CFN95321
    CAS No: 107783-53-9
    Price: $318/20mg
    Gynosaponin TN2

    Catalog No: CFN95331
    CAS No: 77658-95-8
    Price: $318/5mg
    Oxytroflavoside E

    Catalog No: CFN95464
    CAS No: 1391144-84-5
    Price: $318/5mg
    Oxytroflavoside D

    Catalog No: CFN95491
    CAS No: 1391144-83-4
    Price: $318/10mg
    Nomilinic acid

    Catalog No: CFN95559
    CAS No: 35930-20-2
    Price: $318/5mg